Can vision loss due to age be turned around? Scientists at UC Irvine believe so. In a new study, published in Science Translational Medicine, researchers report injecting certain polyunsaturated fatty acids (PUFAs) into the eyes of older mice restored vision and reversed molecular markers of aging.
Points to note:
The research focuses on the ELOVL2 gene, an important lipid metabolism regulator and known aging biomarker.
Increased PUFAs other than DHA improved vision and potentially delayed diseases such as age-related macular degeneration (AMD).
ELOVL2 variants were associated with more rapid AMD development, which could open the way for customized prevention and treatments.
Scientists hope the discovery will lead to anti-aging therapies not just for the eyes but for the immune system.
This breakthrough suggests that targeting the ELOVL2 gene with specific PUFAs could help restore vision and slow age-related eye diseases like AMD. It offers exciting potential for developing personalized anti-aging treatments for both vision and overall immune health.
This is amazing! For diseases like AMD, PUFA injections that target the ELOVL2 gene could be a game-changer in reversing age-related vision loss . Exciting opportunities for individualised eye care are presented by the concept of customising prevention based on genetic variations. The way that research on lipid metabolism is gaining attention is astounding. Do you believe that these treatments may soon be tested on humans instead of mice?